Keith Al‐Hasani

1.6k citations
29 papers · 815 indexed · h-index 15
Topics
Pancreatic function and diabetes (9 papers)Escherichia coli research studies (7 papers)Epigenetics and DNA Methylation (6 papers)

In The Last Decade

Keith Al‐Hasani

29 papers receiving 800 citations

Peers

Keith Al‐Hasani
Comparison fields: 5 of 76
  • Genetics 232
  • Molecular Biology 228
  • Endocrinology 226
  • Surgery 216
  • Microbiology 186
Replace K. Karlsson with:
K. Karlsson Sweden
Anne Jamet France
Philippe Langella France
Ann E. Lin Canada
Dawn M. O’Dee United States
Eleanor S. Metcalf United States
A. Alicia Koblansky United States
Gaëlle Le Negrate United States
Shuzo Kashiba Japan
Shivangi Agarwal United States
Keith Al‐Hasani relative to K. Karlsson Sweden K. Karlsson's profile →
Citations per field
00.5×10×15×20×24.5×
K. Karlsson · 1×
Citations per year

Countries citing papers authored by Keith Al‐Hasani

Since Specialization
Citations

This map shows the geographic impact of Keith Al‐Hasani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Al‐Hasani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Al‐Hasani more than expected).

Fields of papers citing papers by Keith Al‐Hasani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Al‐Hasani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Al‐Hasani. The network helps show where Keith Al‐Hasani may publish in the future.

Co-authorship network of co-authors of Keith Al‐Hasani

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Al‐Hasani. A scholar is included among the top collaborators of Keith Al‐Hasani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Al‐Hasani. Keith Al‐Hasani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 9
2 13
3 6
4 6
5 22
6 15
7 20
8 6
9 18
10 24
11 2
12 4
13 158
14 32
15 27
16 41
17 41
18 12
19 8
20 67

About Keith Al‐Hasani

Keith Al‐Hasani is a scholar working on Endocrinology, Microbiology and Virology, having authored 29 papers that have together received 815 indexed citations. Recurring topics across this work include Pancreatic function and diabetes (9 papers), Escherichia coli research studies (7 papers) and Epigenetics and DNA Methylation (6 papers). The work is most often cited by research in Endocrinology (226 citations), Microbiology (186 citations) and Molecular Medicine (51 citations). Keith Al‐Hasani has collaborated with scholars based in Australia, Denmark and Hong Kong. Frequent co-authors include Ben Adler, Harry Sakellaris, John D. Boyce, Tamás Hatfaludi, Kumar Rajakumar, Assam El‐Osta, Roy M. Robins‐Browne, Patrick Collombat, Nouha Ben-Othman and Elisabet Gjernes. Their work appears in journals such as PLoS ONE, Scientific Reports and Developmental Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026